Combination of EP4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells
EP4 拮抗剂 MF-766 与抗 PD-1 的组合可通过调节淋巴细胞和髓系细胞来增强抗肿瘤功效
期刊:Oncoimmunology
影响因子:
doi:10.1080/2162402X.2021.1896643
Yun Wang, Long Cui, Peter Georgiev, Latika Singh, Yanyan Zheng, Ying Yu, Jeff Grein, Chunsheng Zhang, Eric S Muise, David L Sloman, Heidi Ferguson, Hongshi Yu, Cristina St Pierre, Pranal J Dakle, Vincenzo Pucci, James Baker, Andrey Loboda, Doug Linn, Christopher Brynczka, Doug Wilson, Brian B Haines